Literature DB >> 27507336

Intestinal Epithelial Cell Response to Clostridium difficile Flagella.

Jameel Batah1, Imad Kansau2.   

Abstract

Clostridium difficile is the bacterium responsible for most antibiotic-associated diarrhea in North America and Europe. This bacterium, which colonizes the gut of humans and animals, produces toxins that are known to contribute directly to damage of the gut. It is known that bacterial flagella are involved in intestinal lesions through the inflammatory host response. The C. difficile flagellin recognizes TLR5 and consequently activates the NF-κB and the MAPK signaling pathways which elicit the synthesis of pro-inflammatory cytokines. Increasing interest on the role of C. difficile flagella in eliciting this cell response was recently developed and the development of tools to study cell response triggered by C. difficile flagella will improve our understanding of the pathogenesis of C. difficile.

Entities:  

Keywords:  Clostridium difficile flagella; Flagellin FliC; Innate immune response; MAPK; NF-κB; TLR5 signaling

Mesh:

Substances:

Year:  2016        PMID: 27507336     DOI: 10.1007/978-1-4939-6361-4_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Increased sporulation underpins adaptation of Clostridium difficile strain 630 to a biologically-relevant faecal environment, with implications for pathogenicity.

Authors:  Nigel George Ternan; Nicola Diana Moore; Deborah Smyth; Gordon James McDougall; James William Allwood; Susan Verrall; Christopher Ian Richard Gill; James Stephen Gerard Dooley; Geoff McMullan
Journal:  Sci Rep       Date:  2018-11-12       Impact factor: 4.379

2.  Curcumin and capsaicin regulate apoptosis and alleviate intestinal inflammation induced by Clostridioides difficile in vitro.

Authors:  Masoumeh Azimirad; Maryam Noori; Fahimeh Azimirad; Fatemeh Gholami; Kaveh Naseri; Abbas Yadegar; Hamid Asadzadeh Aghdaei; Mohammad Reza Zali
Journal:  Ann Clin Microbiol Antimicrob       Date:  2022-09-26       Impact factor: 6.781

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.